Movatterモバイル変換

[0]ホーム

Prijeđi na sadržaj

BAY 60-6583

Uredi veze

Izvor: Wikipedija

BAY 60-6583

IUPAC ime


2-[6-amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-ylsulfanyl]acetamide

Drugi nazivi

BAY 60–6583

Identifikacija

PubChem^[1]^[2]

ChemSpider^[3]

Jmol-3D slike

N#Cc1c(SCC(N)=O)nc(N)c(C#N)c1-c3ccc(cc3)OCC2CC2

InChI

InChI=1S/C19H17N5O2S/c20-7-14-17(12-3-5-13(6-4-12)26-9-11-1-2-11)15(8-21)19(24-18(14)23)27-10-16(22)25/h3-6,11H,1-2,9-10H2,(H2,22,25)(H2,23,24)^Y
Kod: ZTYHZMAZUWOXNC-UHFFFAOYSA-N^Y

InChI=1/C19H17N5O2S/c20-7-14-17(12-3-5-13(6-4-12)26-9-11-1-2-11)15(8-21)19(24-18(14)23)27-10-16(22)25/h3-6,11H,1-2,9-10H2,(H2,22,25)(H2,23,24)
Kod: ZTYHZMAZUWOXNC-UHFFFAOYAY

Svojstva

Molekulska formula

C₁₉H₁₇N₅O₂S

Molarna masa

379.435

Ukoliko nije drugačije napomenuto, podaci se odnose nastandardno stanje (25 °C, 100 kPa) materijala

Infobox references

BAY 60–6583 je selektivniagonist adenozinskog A_2B receptora.^[4] Pokazano je da pruža zaštitu odishemije (nedostatka kiseonika usled blokade snabdevanja kiseonikom) u srcu i bubrezima test životinja,^[5]^[6] i da je koristan u tretmanu akutnih povreda pluća.^[7] On može da ima niz potencijalnih primena kao selektivni A_2B agonist.

Reference

[uredi |uredi kod]

↑Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑Baraldi PG, Tabrizi MA, Fruttarolo F, Romagnoli R, Preti D. Recent improvements in the development of A(2B) adenosine receptor agonists.Purinergic Signalling. 2008 Dec;4(4):287-303.PMID 18443746
↑Eckle T, Krahn T, Grenz A, Köhler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzschig HK. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.Circulation. 2007 Mar 27;115(12):1581-90.PMID 17353435
↑Grenz A, Osswald H, Eckle T, Yang D, Zhang H, Tran ZV, Klingel K, Ravid K, Eltzschig HK. The reno-vascular A2B adenosine receptor protects the kidney from ischemia.PLoS Medicine. 2008 Jun 24;5(6):e137.PMID 18578565
↑Eckle T, Grenz A, Laucher S, Eltzschig HK. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice.Journal of Clinical Investigation. 2008 Oct;118(10):3301-15.PMID 18787641